Industry: Food and Beverages
Published Date: March-2025
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 197
Report ID: PMRREP35160
The global CBD nutraceuticals market size is anticipated to rise from US$ 10.38 Bn in 2025 to US$ 23.36 Bn by 2032. It is projected to witness a CAGR of 12.3% from 2025 to 2032. The demand is fueled by rising health awareness, legalization trends, and growing acceptance of CBD for several health issues such as stress relief, pain management, and sleep support.
As more people look for natural health solutions, the demand for CBD nutraceuticals is growing internationally. Sales of CBD products reached US$ 7.9 Bn globally in 2023, with US$ 6 Bn coming from the U.S. alone.
Companies like Charlotte's Web and CV Sciences are expanding their CBD-infused product lines, aiming to meet diverse consumer preferences. Adoption is increasing in Europe and Asia Pacific, especially in Germany, the U.K., and Japan, due to evolving regulatory frameworks.
Key Highlights of the CBD Nutraceuticals Market
|
Global Market Attributes |
Key Insights |
|
CBD Nutraceuticals Market Size (2025E) |
US$ 10.38 Bn |
|
Market Value Forecast (2032F) |
US$ 23.36 Bn |
|
Projected Growth (CAGR 2025 to 2032) |
12.3% |
|
Historical Market Growth (CAGR 2019 to 2024) |
11.1% |
Spur in Research and Development in CBD Nutraceuticals Presents Novel Prospects
As per Persistence Market Research, the global CBD nutraceuticals industry witnessed a CAGR of 11.1% in the historical period between 2019 and 2024. In the observed period, expanding research on cannabinoid effects has enhanced scientific credibility and consumer confidence in CBD-based products. Studies published in 2020 and 2021 demonstrated CBD's potential benefits for anxiety, chronic pain, and epilepsy, leading to FDA approval of Epidiolex, the first CBD-based epilepsy drug.
By 2023, over 3,000 clinical trials involving cannabinoids were registered globally, a 45% increase from 2019. Global sales of CBD products reached US$ 7.9 Bn in 2023, indicating a rise in consumer trust.
Increased investment in CBD research and development in North America and Europe has bolstered regulatory support and enhanced acceptance. This, in turn, has expanded the applications of CBD in nutraceuticals, pharmaceuticals, and functional wellness products in the forthcoming period.
Regulatory Clarification of Legal Frameworks Creates More Defined Pathways for Product Development
In the estimated timeframe from 2025 to 2032, the global market for cannabinoid nutraceuticals is likely to showcase a CAGR of 12.3%. Regulatory developments and clarified legal frameworks are shaping the CBD nutraceuticals industry, creating clearer pathways for product development and marketing. In 2023, the U.S. FDA issued new guidance on CBD product regulation, emphasizing safety, labeling, and dosage control, impacting over 3,500 CBD brands.
The European Food Safety Authority (EFSA) has reviewed over 150 novel food applications for CBD-based products, fostering market expansion. Meanwhile, Canada revised its Cannabis Act in 2024, easing restrictions on CBD-infused functional foods and supplements.
Improved regulatory clarity is expected to reduce legal concerns and allow key companies like Charlotte's Web and Canopy Growth to expand their product ranges, hence driving growth in the global CBD trade.
Furthermore, China's 2022 policy shift permitting CBD in cosmetic formulations has increased its market presence in Asia Pacific. As governments continue refining CBD regulations, consumer confidence, investment, and innovation in CBD nutraceuticals are set to rise.
Evolving CBD Delivery Methods Enhance Consumer Accessibility
The consumption of CBD nutraceuticals is influenced by regulatory reforms and clearer legal frameworks, which create well-defined pathways for product development and commercialization. The global dietary supplement industry is projected to reach US$ 177 Bn in 2023, with CBD-infused products gaining popularity as FDA regulations and EU Novel Food approvals evolve.
In response to these reforms, U.S. and European food safety authorities have implemented stricter quality control measures, ensuring standardized formulations of CBD in supplements, gummies, and powders. The functional beverage market, including CBD-infused drinks, experienced a 9% year-over-year growth, reflecting increased consumer confidence.
Moreover, emerging nations, especially in the Asia Pacific, are relaxing regulations surrounding CBD. For example, Japan's CBD market is expected to reach US$ 800 Mn in 2025. As a result, major nutraceutical companies are investing in CBD innovation, expanding distribution options, and clarifying laws regarding hemp-derived CBD. This trend is contributing to the long-term viability of the sector.
Uncertain Regulatory Restrictions and Lack of Quality Standards Hamper the Industry
As the world progresses with research and development in CBD, the industry tends to face obstacles from regulatory uncertainty in certain regions and inconsistent quality standards of the product. The lack of clear guidelines from regulatory bodies like the FDA has restricted large-scale market expansion, creating hesitation among consumers and retailers.
A WHO research published in 2024 highlights concerns over CBD product mislabeling, with 26% containing Additionally, safety concerns regarding potential drug interactions and long-term effects limit widespread adoption. The high cost of CBD extraction and production also affects affordability, further constraining demand. Such factors collectively hinder the CBD nutraceutical market’s growth despite its increasing popularity among Gen-Zs and millennials.
Consumer Preference Towards Plant-Based CBD Opens Novel Avenues
Plant-based CBD solutions are becoming increasingly popular as consumers choose natural remedies over traditional medications. The global trend toward functional foods and supplements has spurred innovation in CBD-infused goods, including drinks, gummies, and capsules, to meet a range of customer demands, as per Glanbia Nutritionals.
A study published by Harvard Health highlights a growing interest in cannabinoids beyond CBD, such as cannabigerol (CBG) and cannabinol (CBN). These compounds are being explored for their potential anti-inflammatory and neuroprotective benefits. This scientific support helps boost consumer confidence, leading to greater adoption of CBD nutraceuticals. The market's progress is predicted to increase investment in clinical research and product innovation, opening up possibilities for the development of plant-based CBD products.
Innovations in CBD Products Shape the Future of Pain Management
In 2025, pain management is projected to dominate the application segment of the CDC nutraceuticals market, holding a 38.2% share. The rising prevalence of chronic pain conditions such as arthritis, migraines, and musculoskeletal disorders is fueling demand for specialized supplements and therapies.
According to the CDC, an estimated 51.6 million U.S. adults suffer from chronic pain, increasing the need for natural and alternative pain management solutions. The preference for non-pharmaceutical approaches, including herbal supplements, CBD-based products, and functional foods, is driving market expansion.
Advancements in formulation technologies are enhancing the efficacy and bioavailability of pain relief supplements, boosting their adoption among consumers seeking safer, long-term solutions.
Consumers Opt for CBD Gummies with Ease of Consumption
CBD tinctures are expected to lead the market in 2025, representing 42.4% of total sales. This growth is attributed to their rapid absorption, precise dosing, and versatility. Consumers are likely to favor tinctures due to their high bioavailability, which allows for a faster onset of effects compared to other CBD formats.
The acceptance of CBD for pain relief, anxiety, and sleep disorders is fueling demand, with Lazarus Naturals and CBDistillery leading innovation by offering full-spectrum and broad-spectrum tinctures with enhanced efficacy.
The FDA's evolving guidelines on CBD are encouraging investments in product standardization and quality assurance, which is increasing customer trust in wellness products made from hemp. As more consumers seek plant-based wellness solutions, CBD tinctures are anticipated to continue to be a preferred choice in the expanding natural health and wellness market.
North America Presents Favorable Climate for Growth of CBD Nutraceuticals
In 2025, North America is anticipated to lead the CBD nutraceuticals industry with a 54.7% market share, driven by the demand for natural wellness products and favorable regulatory shifts in several states in the U.S. and Canada.
The U.S., with its robust healthcare infrastructure and excellent research facilities, is fueling market growth in CBD-infused foods, supplements, and cosmetics, owing to rising demand for plant-based pain management and wellness alternatives.
Companies like PAO Group, Inc. have capitalized on the demand, launching products such as RelaxRX CBD. With ongoing research into cannabinoids and expanding legalization, North America's CBD nutraceutical market is expected to showcase a CAGR of 8.3% through 2032. Such growth is supported by innovations in delivery formats, including gummies, softgels, and beverages, making CBD more accessible to a wider consumer base.
Rising Cultivation of Cannabis in Asia Pacific Fuels Medical Research
Asia Pacific CBD nutraceuticals market is expected to experience substantial growth in 2025 due to legalization and increasing research on CBD's medicinal benefits.
Countries like India and China, with favorable climatic conditions for cannabis cultivation, are emerging as key players in the market. In India, companies like Awshad are actively organizing medical cannabis workshops to educate healthcare professionals on CBD applications, boosting its acceptance in therapeutic sectors.
Japan, South Korea, and China are implementing regulatory changes to promote CBD-based health products, while China is expanding its CBD industry for pharmaceutical and wellness purposes.
As demand for plant-based health solutions grows, Asia Pacific is expected to see a surge in investments and product innovations in CBD nutraceuticals, positioning the region as a major contributor to the global industry.
Legislative Support in Europe Fuels the Demand for CBD Nutraceuticals
The market for CBD nutraceuticals in Europe is anticipated to showcase a CAGR of 9.1% from 2025 to 2032, making it one of the fastest-growing regions in the world. This increase is attributed to chronic health issues, growing consumer awareness, and product availability. Demand for plant-based health remedies is rising in the region, especially for sleep issues, anxiety, and pain management.
After the Cannabis Act was put into effect in April 2024, legalizing some cannabis products for both personal and medicinal use, Germany, the biggest market in Europe, is expected to see substantial growth. This legislative move is projected to increase investment in CBD nutraceuticals while driving sector innovation.
Consumer confidence in CBD-based products is increasing due to ongoing clinical research into the medicinal potential of cannabinoids. To expand their market reach in the coming years, companies are launching new delivery forms, such as CBD-infused edibles and soft gels.
Market players in the global CBD nutraceuticals market are actively pursuing a variety of innovative business growth strategies to enhance their market presence and drive expansion.
The trade strategies include diversifying their product portfolios to offer a broader range of offerings, forming strategic partnerships and collaborations to leverage complementary strengths, engaging in mergers and acquisitions to consolidate resources and capabilities, and expanding their business footprint into new geographic regions or market segments.
Such multifaceted approach aims to capitalize on the growing demand for CBD-based products and strengthen their competitive advantage within the global cannabinoid industry.
Key Industry Developments
|
Report Attributes |
Details |
|
Historical Data/Actuals |
2019 - 2024 |
|
Forecast Period |
2025 - 2032 |
|
Market Analysis Units |
Value: US$ Bn/Mn, Volume: As applicable |
|
Geographical Coverage |
|
|
Segmental Coverage |
|
|
Competitive Analysis |
|
|
Report Highlights |
|
|
Customization and Pricing |
Available upon request |
By Product
By Form
By Application
By Distribution Channel
By Region
To know more about delivery timeline for this report Contact Sales
The market is set to reach US$ 25.15 Bn in 2025.
In 2025, CBD tinctures, popular among adults, are a popular method for consuming CBD, with effects lasting several hours.
GVB Biopharma, Brains, NOW, Dr. CBD Company Limited, dsm-firmenich, and Charlotte's Web, Inc. are a few leading players.
The industry is estimated to rise at a CAGR of 12.3% through 2032.
North America is projected to hold the largest share of the industry in 2025.
